During the past decade, Medical Research South conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 14 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 8 clinical trials were completed. i.e. 800% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical Research South" #1 sponsor was "NuSirt Biopharma" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Seqirus" with 2 trials sponsored and "Abbott Nutrition" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Research South" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 2 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Great Lakes Drug Development, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Medical Research South" are "Hypertension" (3 trials), "Type 2 Diabetes Mellitus" (3 trials), "Acute Coronary Syndrome" (1 trials), "Acute Gout" (1 trials) and "Acute Migraine" (1 trials). Many other conditions were trialed in "Medical Research South" in a lesser frequency.

Most popular intervention types in "Medical Research South" are "Drug" (16 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "High Metformin" (2 trials), "Low Metformin" (2 trials), "Metformin" (2 trials) and "Mid Metformin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Medical Research South" are 18 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Medical Research South". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Medical Research South, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Medical Research South, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".